Tumor suppressor genes (or recessive oncogenes) are a class of cellular genes for which the loss of gene function is associated with the formation of human tumors. This is in contrast to oncogenes whose overexpression or abnormal activation of gene function leads to the transformed phenotype. Retinoblastoma is a tumor of the immature retina that occurs in young children, and has served as a prototypic model system for the study of tumor suppressor genes in human cancer. Two lines of genetic evidence support the notion that the retinoblastoma gene (Rb) plays an important role in normal cellular growth processes: 1) the Rb gene is ubiquitously expressed in normal tissues but is inactivated in a subset of human tumors; 2) functional replacement of the Rb gene suppresses the tumorigenic phenotypes, including growth, of proliferating tumor cells. How Rb functions in vivo, however, is not clear. The broad, long-term objectives of this proposal are to understand how Rb acts at the molecular level to bring about its tumor suppression function and to elucidate the role of Rb in normal cellular growth processes. One clue to Rb function was realized with the discovery that viral oncoproteins such as SV40 T antigen, papilloma virus E7, and adenovirus E1A can bind to the Rb protein. Subsequent structure-function analyses by several groups including ours has supported the hypothesis that these, viral proteins may elicit cell transformation by overriding normal growth controls through sequestration of Rb protein, and that Rb may operate via protein-protein interaction. Indeed, we and others have recently identified a number of cellular proteins that can interact with Rb, but the function of many of these proteins remains elusive. To better understand the mechanism of action of Rb in normal cell growth regulation, the function of its cellular targets, namely Rb-binding proteins (RBPs), must be characterized. We will use our expertise in Rb protein structure and function to identify the structural and biochemical properties of RBPs that determine their unique functional interactions with Rb.
The specific aims of the proposed experiments are 1) to further characterize a novel activity that can regulate Rb interaction with a specific RBP protein E2F, 2) to isolate cDNA clones of RBPs, 3) to assess the role of RBPs as potential regulatory elements of cell proliferation, 4) to determine the structure-function relationship of RBPs that govern their binding affinities for Rb, 5) to characterize the spatial and temporal nature of RBP gene expression during development, the cell cycle and cellular differentiation. Since Rb gene inactivation primarily causes tumors in the immature retinas of young children, it is clear that Rb, though itself a ubiquitous protein, operates in a tissue and developmental stagespecific manner. The last aim, in conjunction with aim (2), will also address the issue if specific RBP proteins exist that might mediate the tissue and developmental stage-specific function of Rb. Overall, the information from our studies will provide a better understanding of Rb tumor suppressor gene function and contribute to our understanding of the molecular nature of human cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057496-03
Application #
2098233
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1992-09-01
Project End
1997-06-30
Budget Start
1994-09-01
Budget End
1995-06-30
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Jiang, G l; Liu, L; Buyse, I M et al. (1999) Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 83:541-6
Huang, S; Shao, G; Liu, L (1998) The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 273:15933-9
He, L; Yu, J X; Liu, L et al. (1998) RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 58:4238-44
Buyse, I M; Huang, S (1997) In vitro analysis of the E1A-homologous sequences of RIZ. J Virol 71:6200-3
Liu, L; Shao, G; Steele-Perkins, G et al. (1997) The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 272:2984-91
Xie, M; Shao, G; Buyse, I M et al. (1997) Transcriptional repression mediated by the PR domain zinc finger gene RIZ. J Biol Chem 272:26360-6
Mock, B A; Liu, L; LePaslier, D et al. (1996) The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10. Genomics 37:24-8
Mock, B A; Coleman, M P; Huang, S (1996) Riz maps to distal chromosome 4 near genes involved in tumorigenesis and nerve degeneration. Mamm Genome 7:637
Buyse, I M; Takahashi, E I; Huang, S (1996) Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics 34:119-21